Clinical Study
Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C
Table 4
Stepwise logistic regression analysis of factors associated with sustained virological response.
| | Odds ratio | 95% CI | value |
| Total () | | | | RVR | 2.293 | 1.325–3.970 | 0.003 | rs12979860 CC type | 2.482 | 1.332–4.627 | 0.004 | Viral load < 40 × 104 IU/mL | 2.227 | 1.342–3.690 | 0.002 | Platelet ≥ 15 × 104/μL | 1.695 | 1.054–2.723 | 0.029 | Genotype 1 () | | | | RVR | 2.786 | 1.487–3.970 | 0.001 | rs12979860 CC type | 2.881 | 1.216–6.827 | 0.016 | Genotype 2 () | | | | Viral load <40 × 104 IU/mL | 3.086 | 1.570–6.060 | 0.001 | RVR | 2.873 | 1.113–7.19 | 0.029 | Platelet ≥ 15 × 104/μL | 2.417 | 1.240–4.714 | 0.010 | N-L ratio > 1.42 | 0.494 | 0.253–0.963 | 0.038 |
|
|
CI: confidence interval; RVR: rapid virological response; N-L ratio: neutrophil-lymphocyte ratio.
|